Salesforce to Borrow $25 Billion – Its Largest Debt Deal Ever – to Fund Massive Buyback
Salesforce eyes up to $25B in bonds—its largest ever—to fund share buybacks, amid AI worries and credit downgrades from Moody's and S&P.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Salesforce eyes up to $25B in bonds—its largest ever—to fund share buybacks, amid AI worries and credit downgrades from Moody's and S&P.
Boeing fixes minor wire scratches on undelivered 737 MAX planes due to a machining mistake. No immediate safety risk, quick repairs ahead, and deliveries still on track for the year despite a short-term slowdown.
MiNK Therapeutics announces a new collaboration with C-Further to advance PRAME-targeted iNKT cell therapy for pediatric cancers, including up to $1.1 million in funding.
Morgan Stanley downgraded Grifols stock to Equal Weight with a lower €11 price target, citing slowdowns in key products like albumin in China and alpha-1.
BofA reaffirms Buy on Vera Therapeutics; Vertex’s povetacicept Phase 3 interim results in IgAN meet expectations but pose no major competitive threat.
Kohl’s Q4 comparable sales fell 2.8% due to snowstorms, but the retailer beat EPS estimates at $1.07. CEO Michael Bender highlighted a stronger balance sheet and positive 2026 outlook as shares surged up to 7%.